Company News

  • FDA approves new drug for children with ADHD

    On March 2, the US FDA has approved a new drug application (NDA) for AZSTARYS (code name: KP415), once a day, for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years and older. Will be commercialized in the United States. To AZSTARYS is a compound capsule dosage f...
    Read more